Logo image of BC

BRUNSWICK CORP (BC) Stock Fundamental Analysis

NYSE:BC - New York Stock Exchange, Inc. - US1170431092 - Common Stock - Currency: USD

43.8  +0.46 (+1.06%)

After market: 43.8 0 (0%)

Fundamental Rating

5

BC gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 30 industry peers in the Leisure Products industry. There are concerns on the financial health of BC while its profitability can be described as average. BC is not valued too expensively and it also shows a decent growth rate. Finally BC also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

BC had positive earnings in the past year.
In the past year BC had a positive cash flow from operations.
BC had positive earnings in each of the past 5 years.
In the past 5 years BC always reported a positive cash flow from operatings.
BC Yearly Net Income VS EBIT VS OCF VS FCFBC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

1.2 Ratios

BC's Return On Assets of 2.29% is fine compared to the rest of the industry. BC outperforms 70.00% of its industry peers.
BC's Return On Equity of 6.88% is fine compared to the rest of the industry. BC outperforms 66.67% of its industry peers.
BC has a Return On Invested Capital of 7.01%. This is in the better half of the industry: BC outperforms 73.33% of its industry peers.
BC had an Average Return On Invested Capital over the past 3 years of 11.29%. This is above the industry average of 8.15%.
The last Return On Invested Capital (7.01%) for BC is well below the 3 year average (11.29%), which needs to be investigated, but indicates that BC had better years and this may not be a problem.
Industry RankSector Rank
ROA 2.29%
ROE 6.88%
ROIC 7.01%
ROA(3y)6.58%
ROA(5y)8.11%
ROE(3y)20.05%
ROE(5y)23.17%
ROIC(3y)11.29%
ROIC(5y)12.56%
BC Yearly ROA, ROE, ROICBC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

1.3 Margins

BC has a better Profit Margin (2.48%) than 70.00% of its industry peers.
BC's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 8.27%, BC belongs to the top of the industry, outperforming 86.67% of the companies in the same industry.
In the last couple of years the Operating Margin of BC has declined.
Looking at the Gross Margin, with a value of 25.79%, BC is doing worse than 63.33% of the companies in the same industry.
BC's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 8.27%
PM (TTM) 2.48%
GM 25.79%
OM growth 3Y-15.92%
OM growth 5Y-7.05%
PM growth 3Y-37.44%
PM growth 5YN/A
GM growth 3Y-2.7%
GM growth 5Y-0.86%
BC Yearly Profit, Operating, Gross MarginsBC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), BC is creating some value.
BC has less shares outstanding than it did 1 year ago.
BC has less shares outstanding than it did 5 years ago.
BC has a worse debt/assets ratio than last year.
BC Yearly Shares OutstandingBC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
BC Yearly Total Debt VS Total AssetsBC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

An Altman-Z score of 2.70 indicates that BC is not a great score, but indicates only limited risk for bankruptcy at the moment.
BC's Altman-Z score of 2.70 is fine compared to the rest of the industry. BC outperforms 63.33% of its industry peers.
BC has a debt to FCF ratio of 8.87. This is a slightly negative value and a sign of low solvency as BC would need 8.87 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 8.87, BC is in line with its industry, outperforming 50.00% of the companies in the same industry.
A Debt/Equity ratio of 1.11 is on the high side and indicates that BC has dependencies on debt financing.
BC has a Debt to Equity ratio of 1.11. This is in the lower half of the industry: BC underperforms 76.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.11
Debt/FCF 8.87
Altman-Z 2.7
ROIC/WACC0.91
WACC7.66%
BC Yearly LT Debt VS Equity VS FCFBC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.3 Liquidity

BC has a Current Ratio of 1.65. This is a normal value and indicates that BC is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.65, BC is doing worse than 66.67% of the companies in the same industry.
BC has a Quick Ratio of 1.65. This is a bad value and indicates that BC is not financially healthy enough and could expect problems in meeting its short term obligations.
BC has a Quick ratio of 0.63. This is in the lower half of the industry: BC underperforms 76.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.65
Quick Ratio 0.63
BC Yearly Current Assets VS Current LiabilitesBC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

4

3. Growth

3.1 Past

The earnings per share for BC have decreased strongly by -48.12% in the last year.
Measured over the past 5 years, BC shows a small growth in Earnings Per Share. The EPS has been growing by 1.13% on average per year.
Looking at the last year, BC shows a very negative growth in Revenue. The Revenue has decreased by -18.19% in the last year.
BC shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.97% yearly.
EPS 1Y (TTM)-48.12%
EPS 3Y-18%
EPS 5Y1.13%
EPS Q2Q%-83.45%
Revenue 1Y (TTM)-18.19%
Revenue growth 3Y-3.6%
Revenue growth 5Y4.97%
Sales Q2Q%-15.2%

3.2 Future

Based on estimates for the next years, BC will show a very strong growth in Earnings Per Share. The EPS will grow by 21.50% on average per year.
BC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.38% yearly.
EPS Next Y-11.18%
EPS Next 2Y7.78%
EPS Next 3Y13.37%
EPS Next 5Y21.5%
Revenue Next Year3.28%
Revenue Next 2Y4.42%
Revenue Next 3Y4.81%
Revenue Next 5Y4.38%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
BC Yearly Revenue VS EstimatesBC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B
BC Yearly EPS VS EstimatesBC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5 10 15

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 9.61, the valuation of BC can be described as very reasonable.
90.00% of the companies in the same industry are more expensive than BC, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 28.29. BC is valued rather cheaply when compared to this.
BC is valuated reasonably with a Price/Forward Earnings ratio of 10.81.
Based on the Price/Forward Earnings ratio, BC is valued cheaply inside the industry as 83.33% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 21.08. BC is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 9.61
Fwd PE 10.81
BC Price Earnings VS Forward Price EarningsBC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

BC's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. BC is cheaper than 80.00% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of BC indicates a somewhat cheap valuation: BC is cheaper than 80.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 10.94
EV/EBITDA 6.86
BC Per share dataBC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

The decent profitability rating of BC may justify a higher PE ratio.
BC's earnings are expected to grow with 13.37% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)8.47
EPS Next 2Y7.78%
EPS Next 3Y13.37%

7

5. Dividend

5.1 Amount

BC has a Yearly Dividend Yield of 3.93%. Purely for dividend investing, there may be better candidates out there.
In the last 3 months the price of BC has falen by -35.06%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
Compared to an average industry Dividend Yield of 4.91, BC pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.52, BC pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.93%

5.2 History

The dividend of BC is nicely growing with an annual growth rate of 13.66%!
BC has paid a dividend for at least 10 years, which is a reliable track record.
BC has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)13.66%
Div Incr Years12
Div Non Decr Years16
BC Yearly Dividends per shareBC Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

BC pays out 86.32% of its income as dividend. This is not a sustainable payout ratio.
BC's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP86.32%
EPS Next 2Y7.78%
EPS Next 3Y13.37%
BC Yearly Income VS Free CF VS DividendBC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M
BC Dividend Payout.BC Dividend Payout, showing the Payout Ratio.BC Dividend Payout.PayoutRetained Earnings

BRUNSWICK CORP

NYSE:BC (4/17/2025, 8:04:00 PM)

After market: 43.8 0 (0%)

43.8

+0.46 (+1.06%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryLeisure Products
Earnings (Last)01-30 2025-01-30/bmo
Earnings (Next)04-24 2025-04-24/bmo
Inst Owners104.85%
Inst Owner Change0.17%
Ins Owners0.85%
Ins Owner Change3.72%
Market Cap2.89B
Analysts76.92
Price Target80.31 (83.36%)
Short Float %5.88%
Short Ratio4.93
Dividend
Industry RankSector Rank
Dividend Yield 3.93%
Yearly Dividend1.67
Dividend Growth(5Y)13.66%
DP86.32%
Div Incr Years12
Div Non Decr Years16
Ex-Date02-24 2025-02-24 (0.43)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.23%
Min EPS beat(2)-5.65%
Max EPS beat(2)10.1%
EPS beat(4)1
Avg EPS beat(4)-1.65%
Min EPS beat(4)-8.11%
Max EPS beat(4)10.1%
EPS beat(8)2
Avg EPS beat(8)-3.13%
EPS beat(12)4
Avg EPS beat(12)-1.83%
EPS beat(16)8
Avg EPS beat(16)2.95%
Revenue beat(2)1
Avg Revenue beat(2)1.19%
Min Revenue beat(2)-4.26%
Max Revenue beat(2)6.64%
Revenue beat(4)1
Avg Revenue beat(4)-2.57%
Min Revenue beat(4)-9.76%
Max Revenue beat(4)6.64%
Revenue beat(8)1
Avg Revenue beat(8)-4.11%
Revenue beat(12)2
Avg Revenue beat(12)-4.06%
Revenue beat(16)5
Avg Revenue beat(16)-2.17%
PT rev (1m)0%
PT rev (3m)-9.14%
EPS NQ rev (1m)-4.19%
EPS NQ rev (3m)-78.63%
EPS NY rev (1m)-4.59%
EPS NY rev (3m)-25.64%
Revenue NQ rev (1m)-0.26%
Revenue NQ rev (3m)-13.77%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.76%
Valuation
Industry RankSector Rank
PE 9.61
Fwd PE 10.81
P/S 0.55
P/FCF 10.94
P/OCF 6.69
P/B 1.53
P/tB 365.43
EV/EBITDA 6.86
EPS(TTM)4.56
EY10.41%
EPS(NY)4.05
Fwd EY9.25%
FCF(TTM)4.01
FCFY9.14%
OCF(TTM)6.55
OCFY14.94%
SpS79.46
BVpS28.71
TBVpS0.12
PEG (NY)N/A
PEG (5Y)8.47
Profitability
Industry RankSector Rank
ROA 2.29%
ROE 6.88%
ROCE 9.85%
ROIC 7.01%
ROICexc 7.46%
ROICexgc 13.73%
OM 8.27%
PM (TTM) 2.48%
GM 25.79%
FCFM 5.04%
ROA(3y)6.58%
ROA(5y)8.11%
ROE(3y)20.05%
ROE(5y)23.17%
ROIC(3y)11.29%
ROIC(5y)12.56%
ROICexc(3y)12.61%
ROICexc(5y)14.42%
ROICexgc(3y)24.11%
ROICexgc(5y)28.09%
ROCE(3y)15.87%
ROCE(5y)17.66%
ROICexcg growth 3Y-26.29%
ROICexcg growth 5Y-12.51%
ROICexc growth 3Y-22.36%
ROICexc growth 5Y-13.21%
OM growth 3Y-15.92%
OM growth 5Y-7.05%
PM growth 3Y-37.44%
PM growth 5YN/A
GM growth 3Y-2.7%
GM growth 5Y-0.86%
F-Score5
Asset Turnover0.92
Health
Industry RankSector Rank
Debt/Equity 1.11
Debt/FCF 8.87
Debt/EBITDA 2.91
Cap/Depr 57.96%
Cap/Sales 3.2%
Interest Coverage 3.09
Cash Conversion 59.74%
Profit Quality 202.92%
Current Ratio 1.65
Quick Ratio 0.63
Altman-Z 2.7
F-Score5
WACC7.66%
ROIC/WACC0.91
Cap/Depr(3y)110.64%
Cap/Depr(5y)120.16%
Cap/Sales(3y)4.47%
Cap/Sales(5y)4.44%
Profit Quality(3y)112.61%
Profit Quality(5y)110.96%
High Growth Momentum
Growth
EPS 1Y (TTM)-48.12%
EPS 3Y-18%
EPS 5Y1.13%
EPS Q2Q%-83.45%
EPS Next Y-11.18%
EPS Next 2Y7.78%
EPS Next 3Y13.37%
EPS Next 5Y21.5%
Revenue 1Y (TTM)-18.19%
Revenue growth 3Y-3.6%
Revenue growth 5Y4.97%
Sales Q2Q%-15.2%
Revenue Next Year3.28%
Revenue Next 2Y4.42%
Revenue Next 3Y4.81%
Revenue Next 5Y4.38%
EBIT growth 1Y-45.12%
EBIT growth 3Y-18.95%
EBIT growth 5Y-2.43%
EBIT Next Year44.99%
EBIT Next 3Y23.04%
EBIT Next 5Y22.27%
FCF growth 1Y-40.58%
FCF growth 3Y-4.9%
FCF growth 5Y5.54%
OCF growth 1Y-41.19%
OCF growth 3Y-9.08%
OCF growth 5Y-0.13%